Pure Global
NCT06103591

Controlled Arterial Protection to Ultimately Remove Embolic Material

EmStop Inc·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Aortic Valve Stenosis
Drug/Device/Intervention
The EmStop Embolic Protection System (EmStop System)
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
EmStop Inc
Location
Asheville,Nashville, United States of America
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2023
End date
Mar 01, 2024
Enrollment
15 participants
Primary outcome

Device procedural success

Summary

The objective of this study is to demonstrate device feasibility, safety and investigate
 performance of the EmStop Embolic Protection System when used as indicated in 15 subjects at
 2 investigational sites in the U.S.

ICD-10 classifications
Aortic (valve) stenosisAortic (valve) stenosis with insufficiencyCongenital stenosis of aortic valveStenosis of aortaRheumatic aortic stenosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06103591
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06103591 through Pure Global AI's free database. This phase not specified trial is sponsored by EmStop Inc and is currently Not yet recruiting. The study focuses on Aortic Valve Stenosis. Target enrollment is 15 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.